TBIO Translate Bio, Inc. Stock Quote

TBIO [NASD]

Index	-	P/E	-	EPS (ttm)	-1.11	Insider Own	0.70%	Shs Outstand	73.18M	Perf Week	-4.02%
Market Cap	1.56B	Forward P/E	-	EPS next Y	-0.70	Insider Trans	-21.90%	Shs Float	67.18M	Perf Month	-7.96%
Income	-64.30M	PEG	-	EPS next Q	-0.08	Inst Own	87.40%	Short Float	7.58%	Perf Quarter	13.59%
Sales	91.30M	P/S	17.06	EPS this Y	-1.70%	Inst Trans	-6.96%	Short Ratio	4.05	Perf Half Y	58.47%
Book/sh	5.00	P/B	4.40	EPS next Y	111.80%	ROA	-12.80%	Target Price	32.25	Perf Year	183.61%
Cash/sh	9.51	P/C	2.31	EPS next 5Y	-	ROE	-27.50%	52W Range	6.80 - 34.64	Perf YTD	19.26%
Dividend	-	P/FCF	6.74	EPS past 5Y	-	ROI	-75.10%	52W High	-38.08%	Beta	-
Dividend %	-	Quick Ratio	5.70	Sales past 5Y	-	Gross Margin	-	52W Low	215.44%	ATR	2.13
Employees	93	Current Ratio	5.70	Sales Q/Q	1221.10%	Oper. Margin	-72.70%	RSI (14)	39.86	Volatility	7.83% 8.89%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	155.50%	Profit Margin	-70.40%	Rel Volume	0.65	Prev Close	21.98
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	1.26M	Price	21.45
Recom	1.60	SMA20	-17.47%	SMA50	-9.70%	SMA200	16.54%	Volume	811,312	Change	-2.41%

Oct-05-20

Initiated

Goldman

Buy

$19

Jul-07-20

Reiterated

H.C. Wainwright

Buy

$18 → $32

Jul-06-20

Initiated

William Blair

Outperform

Jun-26-20

Initiated

SunTrust

Buy

$40

Jul-22-19

Initiated

Jefferies

Buy

$20

Jun-18-19

Initiated

ROTH Capital

Buy

$25

Dec-24-18

Initiated

H.C. Wainwright

Buy

$21

Jul-23-18

Initiated

Leerink Partners

Outperform

$24

Jul-23-18

Initiated

Evercore ISI

Outperform

$25

Jul-23-18

Initiated

Citigroup

Buy

$20

Mar-03-21 04:05PM	Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Feb-25-21 04:05PM	Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress GlobeNewswire
Feb-18-21 07:30AM	Translate Bio to Present at the SVB Leerink Virtual 10th Annual Global Healthcare Conference GlobeNewswire -7.11%
Feb-14-21 05:12AM	Sanofis COVID-19 Vaccine With Translate Bio Delayed Until Next Year Report SmarterAnalyst
Feb-10-21 03:54PM	Screen Of The Day: Big Money Is Snapping Up These Growth Stocks Investor's Business Daily
Feb-06-21 08:00AM	Zoom Video Leads Five Stocks Racing Past Buy Points Investor's Business Daily
Feb-03-21 04:30PM	Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire +6.32%
Jan-07-21 07:30AM	Translate Bio Announces Timing of Interim Results from mRNA Therapeutic Clinical Trial in Patients with Cystic Fibrosis; Data Expected in Early Q2 2021 GlobeNewswire +5.34%
Dec-22-20 04:20PM	Translate Bio Announces Departure of Chief Financial Officer GlobeNewswire
Dec-02-20 11:17AM	Is Moderna Stock A Buy As It Seeks Authorization For Its Covid Vaccine? Investor's Business Daily
Nov-30-20 01:56PM	The Zacks Analyst Blog Highlights: INO, NVAX, TBIO and VXRT Zacks +14.83%
Nov-17-20 06:04AM	3 mRNA Coronavirus Vaccine Stocks to Check Out That Aren't Pfizer, BioNTech, or Moderna Motley Fool
Nov-12-20 07:30AM	Translate Bio to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-09-20 04:12PM	Game Changer: Pfizer Coronavirus Vaccine Is At Least 90% Effective Investor's Business Daily
Nov-05-20 04:21PM	Translate Bio Announces Third Quarter 2020 Financial Results and Reviews Recent Progress GlobeNewswire
Nov-02-20 04:33PM	CureVac Posts Positive Early Data For Its Covid-19 Vaccine Candidate Investor's Business Daily
Nov-01-20 10:03AM	4 Biotech Companies Working On RNA Therapies Benzinga
Oct-16-20 01:01PM	Sanofi's mRNA Vaccine for Coronavirus to Enter Clinical Stage Zacks
Oct-15-20 04:23PM	Sanofi, Translate Bio Post Positive Early Covid-19 Vaccine Results; Plan Human Testing Investor's Business Daily +5.02%
01:53PM	Sanofi and Translate Bio Have a COVID-19 Vaccine Candidate Ready for Clinical Trials Motley Fool
08:00AM	Sanofi reports positive animal test results for potential COVID-19 vaccine Reuters
08:00AM	Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies GlobeNewswire
Oct-11-20 11:01AM	Goldman Sachs: 2 Strong Value Stocks to Buy Now TipRanks
Oct-07-20 04:05PM	Translate Bio Highlights mRNA Platform Potential for the Treatment of Cystic Fibrosis (CF) at the 34th Annual North American Cystic Fibrosis Conference GlobeNewswire
12:07PM	Translate Bio (NASDAQ:TBIO) Is In A Strong Position To Grow Its Business Simply Wall St.
Sep-29-20 04:05PM	Translate Bio to Participate in Upcoming Investor Conferences GlobeNewswire
Sep-28-20 06:42PM	Hedge Funds Have Never Been This Bullish On Translate Bio, Inc. (TBIO) Insider Monkey
Sep-17-20 01:12PM	Coronavirus Stocks: Can mRNA From Covid Fight Be Used To Cure Cancer? Investor's Business Daily
Sep-08-20 07:30AM	Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis GlobeNewswire
Sep-03-20 04:12PM	Novavax Posts Good Covid Vaccine Data; Sanofi, GlaxoSmithKline Start First Human Tests Investor's Business Daily
07:30AM	Translate Bio to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-14-20 04:55PM	Xerox and Inozyme See Activist Action Barrons.com
Aug-06-20 04:14PM	Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress GlobeNewswire
Jul-31-20 04:55PM	INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Translate Bio, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm Business Wire
Jul-30-20 03:52PM	Seth Klarman Says Fed Is Infantilizing Investors in Surreal Market Bloomberg
11:30AM	Has Translate Bio (TBIO) Outpaced Other Medical Stocks This Year? Zacks
Jul-23-20 12:45PM	Is a Beat in Store for Translate Bio (TBIO) in Q2 Earnings? Zacks
Jul-22-20 12:33PM	Translate Bio, Inc. (TBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Jul-20-20 04:05PM	Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases GlobeNewswire
Jul-14-20 11:30AM	Is Translate Bio (TBIO) Outperforming Other Medical Stocks This Year? Zacks +5.41%
Jul-08-20 09:05AM	The Zacks Analyst Blog Highlights: Alpine Immune Sciences, Actinium Pharmaceuticals, Pacira BioSciences and Translate Bio Zacks
Jul-02-20 10:38PM	Heron Therapeutics (HRTX) in Focus: Stock Moves 9% Higher Zacks
Jul-01-20 06:03PM	Seth Klarman Ups Stake in Translate Bio GuruFocus.com
10:35AM	Insider Buys Translate Bio's Shares Benzinga
Jun-29-20 08:49AM	Are Options Traders Betting on a Big Move in Translate Bio (TBIO) Stock? Zacks
Jun-25-20 11:15PM	Translate Bio (TBIO) in Focus: Stock Moves 11.7% Higher Zacks -7.46%
09:36PM	Translate Bio Announces Pricing of Public Offering of Common Stock GlobeNewswire
03:26PM	Acquiring Biomarin Would Speed Sanofi Transition to New Therapies GuruFocus.com
07:02AM	New Forecasts: Here's What Analysts Think The Future Holds For Translate Bio, Inc. (NASDAQ:TBIO) Simply Wall St.
Jun-24-20 04:18PM	Translate Bio Announces Proposed Public Offering of Common Stock GlobeNewswire +11.69%
09:33AM	Translate Bio Up on Vaccine Agreement Expansion With Sanofi Zacks
09:29AM	Company News for Jun 24, 2020 Zacks
Jun-23-20 02:38PM	Coronavirus update: U.S. case tally surging with more than half the states trending up as death toll tops 120,000 MarketWatch +46.98%
01:42PM	Sanofi Accelerates Coronavirus Vaccine Timeline, Says Approval Could Come In First Half Of 2021 Benzinga
11:40AM	Sanofi Expands Agreement With Translate Bio for mRNA Vaccines Zacks
10:38AM	Translate Bio Joins With Sanofi to Make Covid-19 Vaccines TheStreet.com
10:28AM	Translate Bio Stock Up 50% as Sanofi Commits $1.9 Billion to Its Covid-19 Vaccine Barrons.com
07:57AM	The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout Benzinga
06:21AM	Sanofi Targets Speedier Approval of Coronavirus Vaccine Bloomberg
03:57AM	Sanofi, Translate Bio Ramp Up Billion-Dollar mRNA Vaccine Collaboration SmarterAnalyst
01:48AM	Sanofi clinches $2 billion vaccines deal with Translate Bio Reuters
01:21AM	Sanofi and Translate Bio expand vaccine collaboration Reuters
12:59AM	Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas GlobeNewswire
Jun-14-20 08:24PM	Hedge Funds Are Selling Translate Bio, Inc. (TBIO) Insider Monkey
11:16AM	Sanofi Leads Second Tier of R&D Spenders GuruFocus.com
Jun-03-20 11:41AM	Will Translate Bio Continue to Surge Higher? Zacks -18.64%
May-28-20 07:30AM	Translate Bio to Present at Jefferies Virtual Healthcare Conference GlobeNewswire
May-14-20 11:51AM	Coronavirus Vaccine Progress Accelerates Yahoo Finance
08:47AM	Sanofi CEO Says Americans to Get Potential Virus Vaccine First SmarterAnalyst
May-12-20 04:05PM	Translate Bio to Present at the Bank of America Securities Virtual 2020 Healthcare Conference GlobeNewswire -6.18%
May-08-20 06:16PM	Translate Bio Boosted by Sanofi Vaccine Agreement GuruFocus.com +10.60%
May-07-20 04:26PM	Translate Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
12:30PM	Translate Bio Inc (TBIO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-26-20 04:55AM	Translate Bio Pops 24% On Sanofis Covid-19 Vaccine Enthusiasm SmarterAnalyst
Apr-20-20 06:12PM	Sanofi Partners With Translate Bio on Covid-19 Vaccine GuruFocus.com
Apr-17-20 11:35AM	Moderna Banks on Unproven Technology to Develop Covid-19 Vaccine GuruFocus.com
Apr-14-20 04:41PM	Seth Klarman Dials Down Akebia Therapeutics Stake GuruFocus.com
Mar-30-20 10:41AM	Translate Bio, Sanofi to Jointly Develop Coronavirus Vaccine Zacks +6.20%
08:47AM	Translate Bio (TBIO) Surges: Stock Moves 5.5% Higher Zacks
Mar-27-20 04:33PM	Another mRNA Company Announced a Covid-19 Vaccine Program Barrons.com +5.46%
04:10PM	Covid Report: Biotech Jumps On Deal With Sanofi For Coronavirus Vaccine Investor's Business Daily
02:20PM	Covid Report: Biotech Inks Deal With Sanofi For Coronavirus Vaccine Investor's Business Daily
08:02AM	The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance Benzinga
02:00AM	Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19 GlobeNewswire
Mar-26-20 04:30PM	Translate Bio Provides MRT5005 Program Updates GlobeNewswire
04:30PM	Translate Bio Provides MRT5005 Program Updates Globenewswire Test
Mar-12-20 08:35PM	Translate Bio, Inc. (TBIO) Reports Q4 Loss, Tops Revenue Estimates Zacks +8.88%
04:45PM	Translate Bio Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Progress GlobeNewswire
12:30PM	Earnings Preview: Translate Bio, Inc. (TBIO) Q4 Earnings Expected to Decline Zacks
Feb-26-20 07:30AM	Translate Bio Receives FDA Fast Track Designation for MRT5005 for the Treatment of Cystic Fibrosis GlobeNewswire
Feb-19-20 07:30AM	Translate Bio to Present at Upcoming Investor Conferences GlobeNewswire
Dec-14-19 05:18PM	Translate Bio, Inc. (TBIO): Are Hedge Funds Right About This Stock? Insider Monkey
Dec-12-19 04:15PM	Translate Bio Announces Executive Leadership Appointments GlobeNewswire +5.32%
Dec-10-19 12:22PM	Seth Klarman Pares Paratek Pharmaceuticals Stake GuruFocus.com
Nov-27-19 09:45AM	5 Strong Buy Biotech Stocks With More Than 80% Upside InvestorPlace +5.39%
Nov-14-19 11:56AM	We're Hopeful That Translate Bio (NASDAQ:TBIO) Will Use Its Cash Wisely Simply Wall St.
Nov-13-19 07:30AM	Translate Bio to Present at Upcoming Investor Conferences GlobeNewswire
Nov-06-19 07:25PM	Translate Bio, Inc. (TBIO) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:11PM	Translate Bio Announces Third Quarter 2019 Financial Results and Reviews Recent Highlights GlobeNewswire
Oct-31-19 12:15PM	Translate Bio Presents MRT5005 Data at the 33rd Annual North American Cystic Fibrosis Conference GlobeNewswire

Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 to treat ornithine transcarbamylase deficiency. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. was founded in 2011 and is headquartered in Lexington, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Renaud Ronald C JR	Chief Executive Officer, Pres.	Jan 14	Option Exercise	7.39	5,639	41,673	494,205	Jan 14 07:59 PM
FORMELA JEAN FRANCOIS	Director	Dec 22	Sale	25.07	82,565	2,069,870	43,940	Dec 23 06:07 PM
FORMELA JEAN FRANCOIS	Director	Dec 21	Sale	25.50	56,536	1,441,928	126,505	Dec 23 06:07 PM
Renaud Ronald C JR	Chief Executive Officer, Pres.	Nov 16	Option Exercise	7.39	53,007	391,725	488,566	Nov 18 07:30 PM
FORMELA JEAN FRANCOIS	Director	Aug 27	Sale	14.38	10,097	145,217	3,833,122	Aug 27 08:14 PM
FORMELA JEAN FRANCOIS	Director	Aug 26	Sale	14.80	44,381	656,746	3,843,219	Aug 27 08:14 PM
FORMELA JEAN FRANCOIS	Director	Aug 25	Sale	15.00	34,410	516,160	3,887,600	Aug 27 08:14 PM
Shire Human Genetic Therapies,	10% Owner	Jun 30	Sale	20.68	6,824,992	141,140,835	0	Jun 30 08:24 PM
BAUPOST GROUP LLC/MA	10% Owner	Jun 26	Buy	22.00	500,000	11,000,000	18,044,239	Jun 30 05:37 PM
Shire Human Genetic Therapies,	10% Owner	Jun 03	Sale	19.75	40,086	791,699	6,824,992	Jun 05 09:52 AM
Shire Human Genetic Therapies,	10% Owner	Jun 02	Sale	19.76	105,395	2,082,903	6,865,078	Jun 03 06:08 AM
Shire Human Genetic Therapies,	10% Owner	Jun 01	Sale	19.86	108,472	2,154,121	6,970,473	Jun 03 06:08 AM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience